Cited by 263Cancer, Hypoxia, and MetabolismRenal cell carcinoma treatmentEar and Head Tumors

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor

Open access

Esteban, Miguel A., Tran, Maxine G.B., Harten, Sarah K., Hill, Peter, Castellanos, Maria C., Chandra, Ashish, Raval, Raju, O'Brien, Tim S., Maxwell, Patrick H.·2006·Cancer Research

DOI 10.1158/0008-5472.can-05-2670

Open this paper in CoChat — free account Open PDF

Abstract

Mutations in von Hippel-Lindau tumor suppressor gene (VHL) underlie the VHL hereditary cancer syndrome and also occur in most sporadic clear cell renal cell cancers (CCRCC). Currently, the mechanism(s) by which VHL loss of function promotes tumor development in the kidney are not fully elucidated. Here, we show that VHL inactivation in precancerous lesions in kidneys from patients with VHL disease correlates with marked down-regulation of the intercellular adhesion molecule E-cadherin. Moreover, in VHL-defective cell lines (RCC4 and RCC10) derived from sporadic CCRCC, reexpression of VHL was found to restore E-cadherin expression. The product of the VHL gene has multiple reported functions, the best characterized of which is its role as the recognition component of an ubiquitin E3 ligase complex responsible for mediating oxygen-dependent destruction of hypoxia-inducible factor-α (HIF-α) subunits. We show that HIF activation is necessary and sufficient to suppress E-cadherin in renal cancer cells. Given the fundamental role of E-cadherin in controlling epithelial behavior, our findings give insight into how VHL inactivation/HIF activation may lead to kidney cancer and also indicate a mechanism by which reduced oxygenation could alter E-cadherin expression in other cancers and influence normal homeostasis in other epithelia. (Cancer Res 2006; 66(7): 3567-75)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-2670

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citation
The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression
Cano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
Batlle, E., Sancho, E., Francí, C., Dominguez-Sola, D., Monfar, M., Baulida, J., & de Herreros, A. G. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,730
Multifunctional strands in tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (2001) · Nature reviews. Molecular cell biology · doi:10.1038/35067088 · Cited by 2,578
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719
A causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A. T., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,419

Show all 37 references

Sorted by citations

Items 101–200 of 263

Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway
WANG, Y., Ma, J., SHEN, H., WANG, C., Sun, Y., Howell, S. B., & Lin, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3448 · Cited by 59
Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets
Iliopoulos, O. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8948 · Cited by 59
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma
Santoni, M., Pantano, F., Amantini, C., Nabissi, M., Conti, A., Burattini, L., Zoccoli, A., Berardi, R., Santoni, G., Tonini, G., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.007 · Cited by 60
From critters to cancers: bridging comparative and clinical research on oxygen sensing, HIF signaling, and adaptations towards hypoxia
Hoogewijs, D., Terwilliger, N. B., Webster, K. A., Powell‐Coffman, J. A., Tokishita, S.-I., Yamagata, H., Hankeln, T., Burmester, T., Rytkönen, K. T., Nikinmaa, M., et al. (2007) · Integrative and Comparative Biology · doi:10.1093/icb/icm072 · Cited by 58
Self-citation
Inhibition of Hypoxia-Inducible Factor-1α (HIF-1α) Protein Synthesis by DNA Damage Inducing Agents
Lou, J. J. W., Chua, Y. L., Chew, E., Gao, J., Bushell, M., & Hagen, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010522 · Cited by 57
cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics
Lyle, K. S., Raaijmakers, J. H., Bruinsma, W., Bos, J. L., & de Rooij, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.018 · Cited by 56
Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy
Yotnda, P., Wu, D., & Swanson, A. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_1 · Cited by 59
Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer
Lei, J., Fan, L., Wei, G., Chen, X., Duan, W., Xu, Q., Wei, S., Wang, K., & Li, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2948-z · Cited by 52
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma
Gervais, M. L., Henry, P., Saravanan, A., Burry, T. N., Gallie, B. L., Jewett, M. A. S., Hill, R. P., Evans, A. J., & Ohh, M. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700684 · Cited by 50
Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma
An, J., Liu, H., Magyar, C. E., Guo, Y., Veena, M. S., Srivatsan, E. S., Huang, J., & Rettig, M. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2362 · Cited by 52
PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
Dopeso, H., Jiao, H., Cuesta, Á. M., Henze, A., Jurida, L., Kracht, M., Acker‐Palmer, A., Garvalov, B. K., & Acker, T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1346 · Cited by 52
Low-Oxygen Culture Conditions Extend the Multipotent Properties of Human Retinal Progenitor Cells
Baranov, P. Y., Tucker, B. A., & Young, M. J. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0361 · Cited by 52
HIF-1α Confers Aggressive Malignant Traits on Human Tumor Cells Independent of Its Canonical Transcriptional Function
Yoo, Y., Christensen, J., & Huang, E. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2360 · Cited by 50
Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers
Chen, Y., Chou, H., Lyu, P. C., Yin, H.-S., Huang, F., Chang, W. W., Fan, C., Tu, I., Lai, T.-C., Lin, S., et al. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0210-y · Cited by 50
Downregulation of PHLPP Expression Contributes to Hypoxia-Induced Resistance to Chemotherapy in Colon Cancer Cells
Wen, Y., Stevens, P. D., Gasser, M. L., Andrei, R., & Gao, T. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00695-13 · Cited by 49
Hypoxia-inducible factors and cancer
Calzada, M. J., & del Peso, L. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0055-y · Cited by 48
Ecological paradigms to understand the dynamics of metastasis
Amend, S. R., Roy, S. G., Brown, J. S., & Pienta, K. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.005 · Cited by 45
Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein
Sun, Y. A., Wang, H., Liu, M., Lin, F., & HUA, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2913 · Cited by 45
Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling
Zhang, X., Liang, D., Fan, J., Lian, X., Zhao, Y., Wang, X., Chi, Z., & Zhang, P. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0661-z · Cited by 46
The von Hippel‐Lindau Tumor Suppressor Protein: An Update
Kaelin, W. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35019-2 · Cited by 45
Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells
Harten, S. K., Esteban, M. A., Shukla, D., Ashcroft, M. A., & Maxwell, P. H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-89 · Cited by 44
Self-citation
Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
Ren, X., Diao, X., Zhuang, J., & Wu, D. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000525 · Cited by 45
All along the watchtower: Is the cilium a tumor suppressor organelle?
Mans, D. A., Voest, E. E., & Giles, R. H. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.002 · Cited by 43
Recent advances in renal cell carcinoma from a pathological point of view
Mikami, S., Oya, M., Mizuno, R., Kosaka, T., Ishida, M., Kuroda, N., Nagashima, Y., Katsube, K., & Okada, Y. (2016) · Pathology International · doi:10.1111/pin.12433 · Cited by 42
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis
Khan, M. N., Bhattacharyya, T., Andrikopoulos, P., Esteban, M. A., Barod, R., Connor, T., Ashcroft, M., Maxwell, P. H., & Kiriakidis, S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.73 · Cited by 40
Self-citation
Development of flexible-heteroarotinoids for kidney cancer
Liu, T., Masamha, C. P., Chengedza, S., Berlin, K. D., Lightfoot, S. A., He, F., & Benbrook, D. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1069 · Cited by 39
G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome
Casciello, F., Al-Ejeh, F., Miranda, M., Kelly, G., Baxter, E., Windloch, K., Gannon, F., & Lee, J. S. (2020) · Theranostics · doi:10.7150/thno.41453 · Cited by 31
Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element
Xu, J., Wang, B., Xu, Y., Sun, L. X., Tian, W., Shukla, D., Barod, R., Grillari, J., Grillari‐Voglauer, R., Maxwell, P. H., et al. (2011) · Oncogene · doi:10.1038/onc.2011.305 · Cited by 41
Self-citation
A pathogen-derived effector modulates host glucose metabolism by arginine GlcNAcylation of HIF-1α protein
Xu, C., Liu, X., Zha, H., Fan, S., Zhang, D., Li, S., & Xiao, W. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007259 · Cited by 37
The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies
Garcia, J. A. (2006) · Science s STKE · doi:10.1126/stke.3372006pe25 · Cited by 36
MicroRNA-720 Regulates E-cadherin–αE-catenin Complex and Promotes Renal Cell Carcinoma
Bhat, N. S., Colden, M., Dar, A. A., Saini, S., Arora, P., Shahryari, V., Yamamura, S., Tanaka, Y., Kato, T., Majid, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0400 · Cited by 33
Upregulation of HIF-1α protein induces mitochondrial autophagy in primary cortical cell cultures through the inhibition of the mTOR pathway
Gong, G., Hu, L., LIU, Y., Bai, S., Dai, X., YIN, L., Sun, Y., Wang, X., & Hou, L. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1850 · Cited by 31
RETRACTED: Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma
Maroni, P., Matteucci, E., Drago, L., Banfi, G., Bendinelli, P., & Desiderio, M. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.004 · Cited by 32
Retracted
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 34
Analysis of Hypoxia‐Inducible Factor 1α Expression and its Effects on Invasion and Metastasis
Krishnamachary, B., & Semenza, G. L. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35017-9 · Cited by 32
Molecular Biology of Renal Cortical Tumors
Klatte, T., & Pantuck, A. J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.006 · Cited by 31
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 34
Hypoxia and Metastasis in Breast Cancer
Rundqvist, H., & Johnson, R. S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_77 · Cited by 33
Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.
Lo, U., Bao, J., Cen, J., Yeh, H., Luo, J., Tan, W., & Hsieh, J. (2019) · Europe PMC (PubMed Central) · Cited by 30
Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells
Zeindl‐Eberhart, E., Brandl, L., Liebmann, S., Ormanns, S., Scheel, S. K., Brabletz, T., Kirchner, T., & Jung, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087386 · Cited by 30
VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL
Knauth, K., Cartwright, E. J. P., Freund, S. M. V., Bycroft, M., & Buchberger, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809056200 · Cited by 32
Modulation of cell surface density of carbonic anhydrase IX by shedding of the ectodomain and endocytosis
Zaťovičová, M., & Pastoreková, S. (2013) · Acta Virologica · doi:10.4149/av_2013_02_257 · Cited by 30
Hypoxia and Hypoxia Mimetics Decrease Aquaporin 5 (AQP5) Expression through Both Hypoxia Inducible Factor-1α and Proteasome-Mediated Pathways
Kawedia, J. D., Yang, F., Sartor, M. A., Gozal, D., Czyzyk-Krzeska, M., & Menon, A. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057541 · Cited by 29
Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway
Liu, T., Zhao, L., Chen, W., Li, Z., Hou, H., Ding, L., & Xu, L. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1661 · Cited by 29
Comparative transcriptome analysis reveals physiological responses in liver tissues of Epinephelus coioides under acute hypoxia stress
Lai, X., Zhang, C., Wu, Y., Yang, Y., Zhang, M., Qin, W., Wang, R., & Shu, H. (2022) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2022.101005 · Cited by 28
Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio‐specific changes in the distribution of epidermal adherens junction proteins, aquaporin‐3, and glycogen
Straseski, J. A., Gibson, A. L. F., Thomas‐Virnig, C. L., & Allen‐Hoffmann, B. L. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00515.x · Cited by 28
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau
Roberts, A. M., & Ohh, M. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310de · Cited by 29
Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes
Bangiyeva, V., Rosenbloom, A., Alexander, A. E., Isanova, B., Popko, T., & Schoenfeld, A. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-229 · Cited by 29
Synergistic Signaling of Tumor Cell Invasiveness by Hepatocyte Growth Factor and Hypoxia
Lee, Y. H., Morrison, B. L., & Bottaro, D. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580597 · Cited by 29
Notch in Head and Neck Cancer
Porcheri, C., & Mitsiadis, T. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55031-8_7 · Cited by 29
Interaction of HIF and USF Signaling Pathways in Human Genes Flanked by Hypoxia-Response Elements and E-box Palindromes
Hu, J., Stiehl, D. P., Setzer, C., Wichmann, D., Shinde, D. A., Rehrauer, H., Hradecky, P., Gassmann, M., & Gorr, T. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0090 · Cited by 28
Hypoxia reduces the E-cadherin expression and increases OSCC cell migration regardless of the E-cadherin methylation profile
Domingos, P. L. B., de Souza, M. G., Guimarães, T. A., Santos, E. S., Farias, L. C., Fraga, C. A. D. C., Jones, K. M., Santos, S. H. S., de Paula, A. M. B., & Guimarães, A. L. S. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.02.003 · Cited by 26
VHL and p53: Tumor Suppressors Team Up to Prevent Cancer
Semenza, G. L. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.001 · Cited by 26
Regulation of Inflammation-Mediated Chronic Diseases by Botanicals
Sung, B., Prasad, S., Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2012) · Advances in botanical research · doi:10.1016/b978-0-12-394591-4.00003-9 · Cited by 28
Inhibition of mTORC2 but not mTORC1 Up-Regulates E-Cadherin Expression and Inhibits Cell Motility by Blocking HIF-2α Expression in Human Renal Cell Carcinoma
Maru, S., Ishigaki, Y., Shinohara, N., Takata, T., Tomosugi, N., & Nonomura, K. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.010 · Cited by 25
Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories
Martin, A. R., Ronco, C., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00432f · Cited by 27
Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
Ceranski, A. K., Carreño-Gonzalez, M. J., Ehlers, A. C., Colombo, M. V., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01750-w · Cited by 25
Key Role for Activin B in Cellular Transformation after Loss of the von Hippel-Lindau Tumor Suppressor
Wacker, I., Sachs, M., Knaup, K. X., Wiesener, M. S., Weiske, J., Huber, O., Akçetin, Z., & Behrens, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01184-07 · Cited by 25
Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
Tanaka, T., Ikegami, Y., Nakazawa, H., Kuriyama, N., Oki, M., Hanai, J.-I., Sukhatme, V. P., & Kaneki, M. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25411 · Cited by 23
Lysyl Oxidase and Lysyl Oxidase-Like Enzymes
Kagan, H. M., & Ryvkin, F. (2010) · Springer eBooks · doi:10.1007/978-3-642-16555-9_9 · Cited by 23
Renal involvement in tuberous sclerosis complex and von Hippel–Lindau disease: shared disease mechanisms?
Siroky, B. J., Czyzyk-Krzeska, M., & Bissler, J. J. (2009) · Nature Reviews Nephrology · doi:10.1038/ncpneph1032 · Cited by 23
Isoflurane inhibits occludin expression via up-regulation of hypoxia-inducible factor 1α
Zhao, J., Hao, J., Fei, X., Wang, X., Hou, Y., & Deng, C. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.025 · Cited by 22
Hypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
Hansen, A. E., Kristensen, A. T., Law, I. G., Jørgensen, J. T., & Engelholm, S. A. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00233.x · Cited by 23
[Hypoxia in cancer malignity. Review].
Arvelo, F. A., & Cotte, C. (2009) · PubMed · Cited by 22
Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma
Broncy, L., Njima, B. B., Méjean, A., Béroud, C., Romdhane, K. B., Ilié, M., Hofman, V., Muret, J. C., Hofman, P. M., Chaabouni-Bouhamed, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25102 · Cited by 22
The von Hippel–Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2
Essers, P., Klasson, T. D., Pereboom, T. C., Mans, D. A., Nicastro, M., Boldt, K., Giles, R. H., & MacInnes, A. W. (2014) · Oncogene · doi:10.1038/onc.2013.598 · Cited by 21
Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation
Ji, Q., & Burk, R. D. (2008) · Biochemistry and Cell Biology · doi:10.1139/o08-035 · Cited by 21
Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma
Gasińska, A., Jaszczyński, J., Adamczyk, A., Janecka-Widła, A., Wilk, W., Cichocka, A., & Stelmach, A. (2018) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2018.0023 · Cited by 19
Von Hippel-Lindau syndrome: molecular mechanisms of the disease
Calzada, M. J. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0485-9 · Cited by 21
E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma
Gao, Y., Li, H., Ma, X., Yang, F., Ni, D., Zhang, Y., Huang, Q., Liu, K., Li, X., Wang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10568 · Cited by 20
Dose-dependent modulation of HIF-1α/sima controls the rate of cell migration and invasion in Drosophila ovary border cells
Doronkin, S., Djagaeva, I., Nagle, M. E., Reiter, L. T., & Seagroves, T. N. (2009) · Oncogene · doi:10.1038/onc.2009.407 · Cited by 19
Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells
Feijoo‐Cuaresma, M., Méndez, F., Maqueda, A., Esteban, M. A., Naranjo‐Suarez, S., Castellanos, M. C., del Cerro, M. H., Vazquez, S. N., García-Pardo, A., Landázuri, M. O., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709390200 · Cited by 20
Self-citation
Molecular mechanisms and functions of autophagy and the ubiq-uitin-proteasome pathway
Chen, K., Cheng, H., & Zhou, R. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.00005 · Cited by 19
Why do tumors metastasize?
López‐Lázaro, M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3950 · Cited by 18
HIF-2α downregulation in the absence of functional VHL is not sufficient for renal cell differentiation
Hughes, M. D., Kapllani, E., Alexander, A. E., Burk, R. D., & Schoenfeld, A. R. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-13 · Cited by 18
Cadherin Expression, Vectorial Active Transport, and Metallothionein Isoform 3 Mediated EMT/MET Responses in Cultured Primary and Immortalized Human Proximal Tubule Cells
Slusser-Nore, A., Bathula, C. S., Sens, D. A., Somji, S., Sens, M. A., Zhou, X., & Garrett, S. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120132 · Cited by 17
Knockdown of von Hippel–Lindau protein decreases lung cancer cell proliferation and colonization
Zhou, Q., Chen, T., Ibe, J. C. F., Raj, J. U., & Zhou, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.009 · Cited by 18
Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer
Lee, C.-L., Tsai, C., Yeh, D., Lin, C.-S., Li, Y., & Tzeng, H.-E. (2016) · Oncotarget · doi:10.18632/oncotarget.13679 · Cited by 17
Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma
Jumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Kosyreva, A. M., & Fatkhudinov, T. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111616 · Cited by 19
Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression
Wiesener, M. S., Maxwell, P. H., & Eckardt, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0504-x · Cited by 16
Self-citation
Modulating hypoxia inducible factor‐1 by nanomaterials for effective cancer therapy
Sun, Y. H., Zhou, Z., Yang, S., & Yang, H. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1766 · Cited by 16
HIF1α deficiency reduces colon inflammation in a mouse model of proximal colon cancer
Mladenova, D. N., Dahlstrom, J. E., Tran, P. N., Benthani, F. A., Bean, E. G., Ng, I., Pangon, L., Currey, N., & Kohonen‐Corish, M. R. J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019000 · Cited by 16
Snail predicts recurrence and survival of patients with localized clear cell renal cell carcinoma after surgical resection
Liu, W., Liu, Y., Liu, H., Zhang, W., An, H., & Xu, J. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.08.003 · Cited by 16
RNA interference-mediated silencing of speckle-type POZ protein promotes apoptosis of renal cell cancer cells
Sun, G.-L., Liu, X., & Sun, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s91097 · Cited by 16
TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation
Fan, S., Wang, J., Yu, G., Rong, F., Zhang, D., Xu, C., Du, J., Li, Z., Ouyang, G., & Xiao, W. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014538 · Cited by 16
Is Co-option a Prevailing Mechanism during Cancer Progression?
Billaud, M., & Santoro, M. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2158 · Cited by 17
The “Sharp”blade against HIF-mediated metastasis
Amelio, I., & Melino, G. (2012) · Cell Cycle · doi:10.4161/cc.22820 · Cited by 15
Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma
Elbanna, M., Orillion, A. R., Damayanti, N. P., Adelaiye-Ogala, R. M., Shen, L., Miles, K. M., Chintala, S., Ciamporcero, E. S., Ramakrishnan, S., Ku, S., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1202 · Cited by 15
Proteome dynamics analysis identifies functional roles of SDE2 and hypoxia in DNA damage response in prostate cancer cells
Luo, A., Gong, Y., Kim, H., & Chen, Y. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa010 · Cited by 14
A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer
Grubb, T. M., Maganti, S., Krill-Burger, J. M., Fraser, C. S., Stransky, L. A., Radivoyevitch, T., Sarosiek, K. A., Vázquez, F., Kaelin, W. G., & Chakraborty, A. A. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0669 · Cited by 18
Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions
Azzi, S., Gallerne, C., Romei, C., Coz, V. L., Gangemi, R. M. R., Khawam, K., Devocelle, A., Gu, Y., Bruno, S., Ferrini, S., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.06.002 · Cited by 15
Implications of Oxygen Homeostasis for Tumor Biology and Treatment
Garvalov, B. K., & Acker, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_12 · Cited by 17
Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma
Vacas, E., Bajo, A. M., Schally, A. V., Sánchez‐Chapado, M., Prieto, J. C., & Carmena, M. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.021 · Cited by 14
Bone marrow‐derived mesenchymal stem cells differentiation into tubular epithelial‐like cells in vitro
Wan, J., Zou, Z., You, D., Cui, J., & Pan, Y. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1826 · Cited by 14
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13
In Vitro Effects of Hypoxia-Inducible Factor 1a on the Biological Characteristics of the SiHa Uterine Cervix Cancer Cell Line
Tang, B., Qu, Y., Zhao, F., Mao, M., Tang, J., Li, X., Ferriero, D. M., & Mu, D. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a14f9a · Cited by 12
The protein tyrosine phosphatase receptor type J is regulated by the pVHL–HIF axis in clear cell renal cell carcinoma
Casagrande, S., Ruf, M., Rechsteiner, M., Morra, L., Brun‐Schmid, S., von Teichman, A., Krek, W., Schraml, P., & Moch, H. (2012) · The Journal of Pathology · doi:10.1002/path.4107 · Cited by 12
Role of nuclear receptors in breast cancer stem cells
Papi, A., & Orlandi, M. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.62 · Cited by 12
Hypoxia, Gene Expression, and Metastasis
Razorenova, O. V., & Giaccia, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_3 · Cited by 11

Authors: Esteban, M. A., Tran, M. G. B., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., Raval, R., O'Brien, T. S., & Maxwell, P. H.
Affiliations: Imperial College London (GB)
3Servicio de Immunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain; and
Guy's Hospital (GB)
4Henry Wellcome Building of Genomic Medicine, Oxford, United Kingdom
2Department of Urology, Guy's Hospital, London Bridge, London, United Kingdom;
ORCID: Esteban, Miguel A.
Tran, Maxine G.B.
Chandra, Ashish
Raval, Raju
Maxwell, Patrick H.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2006-04-01
Volume: 66
Issue: 7
Pages: 3567-3575
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-05-2670
OpenAlex: W2039412091
Cited by: 262
References: 37
Citations by year: 2026: 2 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 5 · 2016: 14 · 2015: 14 · 2014: 18 · 2013: 17 · 2012: 19
FWCI: 10.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Wellcome Trust
European Commission
Medical Research Council
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Health Sciences › Medicine › Oncology › Ear and Head Tumors
Keywords: E-cadherin, von Hippel-Lindau tumor suppressor, hypoxia-inducible factor alpha, clear cell renal cell carcinoma, von Hippel-Lindau disease, cell-cell adhesion, epithelial cell adhesion, E3 ubiquitin ligase, tumor suppressor inactivation, oxygenation
MeSH terms: Adult, Carcinoma, Renal Cell, Cell Transformation, Neoplastic, Female, von Hippel-Lindau Disease, Humans, Kidney Neoplasms, Kidney Tubules, Male, Middle Aged, Precancerous Conditions, RNA, Messenger, Down-Regulation, Cadherins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks